Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01534819 · ClinicalTrials.gov registry record

ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry)

A clinical trial of Aortic Aneurysm, sponsored by Medtronic Cardiovascular.

Active
Registry status
1,090
Enrollment target
20
Study locations

NCT01534819 is a study of Aortic Aneurysm that is active but no longer recruiting, run by Medtronic Cardiovascular. The registered enrollment target is 1,090 participants, above the 562-participant average among 14 other Aortic Aneurysm trials with a reported enrollment target (94% higher). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01534819, a study of Aortic Aneurysm, is active but no longer recruiting, sponsored by Medtronic Cardiovascular.

ACTIVE NOT RECRUITING
Registry status
1,090 participants
Enrollment target
20
Study locations

Study Summary

The ANCHOR registry is a multi-center, post-market, non-interventional, non-randomized, prospective study. Subjects must sign an ICF prior to obtaining any study specific information. Subjects are eligible to be consented up to 30 days post-procedure. Enrolled subjects will be followed as per local 'standard of care' for up to 5 years post procedure. Study recommended follow-up is per SVS and ESVS guidance.

Conditions Studied

Aortic Aneurysm

Interventions

  • DEVICE EndoAnchor™
  • PROCEDURE endovascular treament

Study Locations (20)

California

  • VA Loma Linda Medical Center - Loma Linda
  • El Camino Hospital - Mountain View
  • University of California Irvine Medical Center - Torrance
  • Harbor - UCLA Medical Center - Torrance

Florida

  • Baptist Cardiac & Vascular Institute - Miami
  • Florida Hospital - Orlando
  • University of South Florida - Tampa

Illinois

  • HeartCare Midwest - Peoria
  • Evanston Hospital - Skokie
  • Southern Illinois University - Springfield

Maryland

  • University of Maryland Medical Center - Baltimore
  • Johns Hopkins Bayview Medical Center - Baltimore

Alabama

  • University of Alabama - Birmingham

Arizona

  • Abrazo Arizona Heart Institute - Phoenix

Arkansas

  • John L McClellan Memorial Veterans Hospital - Little Rock

Connecticut

  • Yale University School of Medicine - New Haven

Trial Details

FieldValue
Enrollment Target 1,090 participants
Start Date 2012-04
Est. Completion 2026-04-24

Sponsor

Medtronic Cardiovascular

44 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01534819

The ClinicalTrials.gov registry entry for NCT01534819 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,090 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 562-participant average among 14 other Aortic Aneurysm trials with a reported enrollment target (94% higher). The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aortic Aneurysm appearing as the primary indexed condition, and to 2 interventions - of which EndoAnchor™ is the first listed.

NCT01534819 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT01534819 about?

NCT01534819 is a clinical study titled "ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry)". The ANCHOR registry is a multi-center, post-market, non-interventional, non-randomized, prospective study. Subjects must sign an ICF prior to obtaining any study specific information. Subjects are eligible to be consented up to 30 days post-procedure. Enrolled subjects will be followed as per loca...

What is the current status of trial NCT01534819?

This trial is currently active not recruiting. The enrollment target is 1,090 participants. The study started on 2012-04. Estimated completion is 2026-04-24.

What conditions does trial NCT01534819 study?

This clinical trial studies the following conditions: Aortic Aneurysm.

What interventions are being tested in trial NCT01534819?

The interventions under investigation include: EndoAnchor™ (DEVICE), endovascular treament (PROCEDURE).

Who is sponsoring clinical trial NCT01534819?

This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01534819 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Aortic Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Aortic Aneurysm

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.